Back to search
FDAFDA · Food and drugs·Recall number D-0049-2017

HEPARIN Sodium Inj. USP, 3,000 USP Heparin Units per 3 mL Total Volume in a syringe, NOT FOR LOCK FLUSH, 1,000 Heparin USP Units per mL, Rx only, PharMEDium, Product code 2K1926.

Published October 19, 2016 · Recall initiated: July 17, 2015

Summary

FDA records drug Class II recall D-0049-2017, published October 19, 2016 and initiated July 17, 2015. Recalling firm: Pharmedium Services, LLC; Status: Terminated; Reported quantity: 350 syringes; Lot: Lot Numbers: 15138094S, 15148074S, 15152062S, 15159110S, 15180117S, 15183118S, Exp between 07/15/15-10/12/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug and Stability Data Does Not Support Expiry: confirmed subpotency and potential loss of potency in drugs packaged and stored in syringes.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmedium Services, LLC
Distributor
Nationwide
Lot
Lot Numbers: 15138094S, 15148074S, 15152062S, 15159110S, 15180117S, 15183118S, Exp between 07/15/15-10/12/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was HEPARIN Sodium Inj. USP, 3,000 USP Heparin Units per 3 mL Total Volume in a syringe, NOT FOR LOCK FLUSH, 1,000 Heparin USP Units per mL, Rx only, PharMEDium, Product code 2K1926. recalled?

Yes. FDA published recall D-0049-2017 on October 19, 2016. Reported hazard: Subpotent Drug and Stability Data Does Not Support Expiry: confirmed subpotency and potential loss of potency in drugs packaged and stored in syringes.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail